|
THE COMPANY REPORTED INCOME OF 4 CENTS AND a loss of 8-9 cents next. I don't think the analyst had included the extra R&D costs in the 4th quarter (they all knew it was comming) but if you add the two quarters then you get a loss of 4 cents not the expected 11 cent loss.
I believe the best part of the report is the change in revenue (nearly 5mm) with only 700k change in cost of goods sold. OSUR WILL HAVE GREAT MARGINS ONCE THE OTC PRODUCT IS APPROVED. GOOD LUCK. Rating :
 (No ratings) |
44/Male |
|
Page
1
of about
1
First
| < Prev
| Next >
| Last
|
|
Page
1
of about
1
First
| < Prev
| Next >
| Last
|
0.04